These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8526788)

  • 21. LDL-apheresis significantly reduces urinary apo(a) excretion.
    Kostner KM; Jansen M; Maurer G; Derfler K
    Eur J Clin Invest; 1997 Jan; 27(1):93-5. PubMed ID: 9041383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies.
    Richter WO; Jacob BG; Ritter MM; Sühler K; Vierneisel K; Schwandt P
    Metabolism; 1993 Jul; 42(7):888-94. PubMed ID: 8345799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
    Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
    Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of LDL, Lp[a], and reduced Lp[a] with monoclonal antibodies against apoB.
    Gries A; Fievet C; Marcovina S; Nimpf J; Wurm H; Mezdour H; Fruchart JC; Kostner GM
    J Lipid Res; 1988 Jan; 29(1):1-8. PubMed ID: 2451704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
    Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
    Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a) apheresis in severe coronary heart disease: an immunoadsorption method.
    Ullrich H; Lackner KJ; Schmitz G
    Artif Organs; 1998 Feb; 22(2):135-9. PubMed ID: 9491903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is lipoprotein (a)-apheresis useful?
    Bambauer R
    Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns.
    Gandjini H; Gambert P; Athias A; Mousson C; Rifle G; Lallemant C
    Transfus Sci; 1994 Sep; 15(3):289-97. PubMed ID: 10155547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosorbents for LDL-apheresis.
    Pokrovsky SN; Adamova IYu ; Benevolenskaya GF
    Biomater Artif Cells Artif Organs; 1990; 18(5):623-8. PubMed ID: 2099217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Theoretical and experimental substantiation of immunosorption procedures].
    Pokrovskiĭ SN; Adamova IIu; Babiĭ AV
    Kardiologiia; 1986 Oct; 26(10):49-54. PubMed ID: 3795703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis.
    Banyai S; Streicher J; Strobl W; Gabriel H; Gottsauner-Wolf M; Rohac M; Weidinger F; Hörl WH; Derfler K
    Metabolism; 1998 Sep; 47(9):1058-64. PubMed ID: 9751233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
    Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T
    J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biological efficacy of LDL apheresis in major hypercholesterolemia].
    Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G
    Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
    Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center.
    Bosch T; Lennertz A; Kordes B; Samtleben W
    Ther Apher; 1999 Aug; 3(3):209-13. PubMed ID: 10427617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany.
    Heigl F; Hettich R; Lotz N; Reeg H; Pflederer T; Osterkorn D; Osterkorn K; Klingel R
    Atheroscler Suppl; 2015 May; 18():154-62. PubMed ID: 25936320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effect of low-density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow-up study using coronary angiography.
    Saku K; Takeda Y; Jimi S; Okabe M; Shirai K; Nii T; Naito S; Arakawa K
    J Cardiol; 1998 Apr; 31(4):239-45. PubMed ID: 9594373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.
    Bosch T; Schmidt B; Kleophas W; Otto V; Samtleben W
    Artif Organs; 1997 Oct; 21(10):1060-5. PubMed ID: 9335362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.